Longitudinal study of the substantia nigra in Parkinson disease: A high-field1H-MR spectroscopy imaging study

Dopamine Reduction in the Substantia Nigra of Parkinson's Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging

(2014) Adriane Gröger et al.   PLoS One

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Biomarkers in Parkinson’s disease (recent update)

(2013) Sushil Sharma et al.   NEUROCHEMISTRY INTERNATIONAL

Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment

(2012) Kun Nie et al.   PARKINSONISM & RELATED DISORDERS

Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS

(2012) Uzay E. Emir et al.   PLoS One

Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson’s disease

(2011) Adriane Gröger et al.   EUROPEAN RADIOLOGY

Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy

(2007) S.A.M. van Vlieta et al.   BRAIN RESEARCH